{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:41:10Z","timestamp":1790804470112,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T00:00:00Z","timestamp":1570060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T00:00:00Z","timestamp":1570060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004569","name":"Ministerstwo Nauki i Szkolnictwa Wy\u017cszego","doi-asserted-by":"publisher","award":["#508-2100-11-0561"],"award-info":[{"award-number":["#508-2100-11-0561"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministerstwo Nauki i Szkolnictwa Wy\u017cszego","doi-asserted-by":"publisher","award":["#508-2100-11-0476"],"award-info":[{"award-number":["#508-2100-11-0476"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministerstwo Nauki i Szkolnictwa Wy\u017cszego","doi-asserted-by":"publisher","award":["#508-1160-11-0167"],"award-info":[{"award-number":["#508-1160-11-0167"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Systemic sclerosis (SSc) is a complex, heterogeneous connective tissue disease, characterized by fibrosis and ECM deposition in skin and internal organs, autoimmunity, and changes in the microvasculature. Profiling of circulating miRNAs in serum has been found to be changed in pathological states, creating new possibilities for molecular diagnostics as blood-based biomarkers. This study was designed to identify miRNAs that are differentially expressed in SSc and might be potentially contributing to the disease etiopathogenesis or be used for diagnostic purposes. Thus, we compared the expression pattern of multiple miRNAs in serum of 10 SSc patients to 6 healthy controls using microarray analysis, and RT-qPCR to confirm the obtained results. In addition, bioinformatics analysis was performed to explore miRNAs target genes and the signaling pathways that may be potentially involved in SSc pathogenesis. Our study shows a different expression of 15 miRNAs in SSc patients. We identified that miR-4484, located on chromosome 10q26.2, was an 18-fold up-regulated in SSc patients compared to a control group. Bioinformatics analysis of the miR-4484 target genes and the signaling pathways showed that it might be potentially involved in the TGF-\u03b2 signaling pathway, ECM-receptor interaction, and metalloproteinases expression. Based on the chromosomal location, the most interesting target gene of miR-4484 may be MMP-21. We found that the expression of MMP-21 significantly increased in SSc patients compared to healthy subjects (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Our results suggest that miR-4484, and MMP-21 might be novel serum biomarkers that may correspond to pathological fibrosis in SSc, but it needs to be validated in further studies.<\/jats:p>","DOI":"10.1038\/s41598-019-50695-y","type":"journal-article","created":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T10:11:10Z","timestamp":1570097470000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["A novel miRNA-4484 is up-regulated on microarray and associated with increased MMP-21 expression in serum of systemic sclerosis patients"],"prefix":"10.1038","volume":"9","author":[{"given":"Marta","family":"Rusek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Michalska-Jakubus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Kowal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Be\u0142towski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Krasowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,3]]},"reference":[{"key":"50695_CR1","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","volume":"6","author":"D Pattanaik","year":"2015","unstructured":"Pattanaik, D., Brown, M., Postlethwaite, B. C. & Postlethwaite, A. E. Pathogenesis of systemic sclerosis. Front. Immunol. 6, 272 (2015).","journal-title":"Front. Immunol."},{"key":"50695_CR2","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.3899\/jrheum.121380","volume":"40","author":"C Muangchan","year":"2013","unstructured":"Muangchan, C. The 15% rule in scleroderma: the frequency of severe organ complications in systemic sclerosis. A systematic review. J. Rheumatol. 40, 1545\u20131556 (2013).","journal-title":"A systematic review. J. Rheumatol."},{"key":"50695_CR3","doi-asserted-by":"publisher","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","volume":"1","author":"Y Allanore","year":"2015","unstructured":"Allanore, Y. et al. Systemic sclerosis. Nat Rev Dis Prim. 1, 15002 (2015).","journal-title":"Nat Rev Dis Prim."},{"key":"50695_CR4","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.intimp.2015.07.042","volume":"28","author":"C-G Miao","year":"2015","unstructured":"Miao, C.-G. et al. Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directions. Int. Immunopharmacol. 28, 626\u2013633 (2015).","journal-title":"Int. Immunopharmacol."},{"key":"50695_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/srep42899","volume":"7","author":"B Zhou","year":"2017","unstructured":"Zhou, B. et al. Integration of microRNA and mRNA expression profiles in the skin of systemic sclerosis patients. Sci. Rep. 7, 42899 (2017).","journal-title":"Sci. Rep."},{"key":"50695_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12931-016-0343-6","volume":"17","author":"A Pardo","year":"2016","unstructured":"Pardo, A., Cabrera, S., Maldonado, M. & Selman, M. Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis. Respir. Res. 17, 23 (2016).","journal-title":"Respir. Res."},{"key":"50695_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev.cellbio.23.090506.123406","volume":"23","author":"N Bushati","year":"2007","unstructured":"Bushati, N. & Cohen, S. M. microRNA functions. Annu. Rev. Cell Dev. Biol. 23, 175\u2013205 (2007).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"50695_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0020769","volume":"6","author":"R Duttagupta","year":"2011","unstructured":"Duttagupta, R., Jiang, R., Gollub, J., Getts, R. C. & Jones, K. W. Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS One 6, 1\u201314 (2011).","journal-title":"PLoS One"},{"key":"50695_CR9","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley, D. et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 38, W214\u2013W220 (2010).","journal-title":"Nucleic Acids Res."},{"key":"50695_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/sji.12261","volume":"81","author":"X Deng","year":"2015","unstructured":"Deng, X. et al. The role of microRNAs in autoimmune diseases with skin involvement. Scand. J. Immunol. 81, 153\u2013165 (2015).","journal-title":"Scand. J. Immunol."},{"key":"50695_CR11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jaut.2017.12.015","volume":"89","author":"E Chouri","year":"2018","unstructured":"Chouri, E. et al. Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis. J. Autoimmun. 89, 162\u2013170 (2018).","journal-title":"J. Autoimmun."},{"key":"50695_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2003-5-1-r1","volume":"5","author":"AJ Enright","year":"2003","unstructured":"Enright, A. J. et al. MicroRNA targets in Drosophila. Genome Biol. 5, R1 (2003).","journal-title":"Genome Biol."},{"key":"50695_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jdermsci.2010.11.007","volume":"61","author":"Y Kawashita","year":"2011","unstructured":"Kawashita, Y. et al. Circulating miR-29a levels in patients with scleroderma spectrum disorder. Journal of Dermatological Science 61, 67\u201369 (2011).","journal-title":"Journal of Dermatological Science"},{"key":"50695_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2013.71","volume":"45","author":"H Zhu","year":"2013","unstructured":"Zhu, H., Luo, H. & Zuo, X. MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in scleroderma. Exp. Mol. Med. 45, e41 (2013).","journal-title":"Exp. Mol. Med."},{"key":"50695_CR15","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.3892\/ol.2017.5801","volume":"13","author":"K Zhang","year":"2017","unstructured":"Zhang, K., Wang, Y.-W. & Ma, R. Bioinformatics analysis of dysregulated microRNAs in the nipple discharge of patients with breast cancer. Oncol. Lett. 13, 3100\u20133108 (2017).","journal-title":"Oncol. Lett."},{"key":"50695_CR16","first-page":"927","volume":"11","author":"Z Nawaz","year":"2017","unstructured":"Nawaz, Z. et al. Impact of somatic copy number alterations on the glioblastoma miRNome: miR-4484 is a genomically deleted tumour suppressor. Molecular. Oncology 11, 927\u2013944 (2017).","journal-title":"Oncology"},{"key":"50695_CR17","first-page":"334","volume":"41","author":"G Tamaddon","year":"2016","unstructured":"Tamaddon, G., Geramizadeh, B., Karimi, M. H., Mowla, S. J. & Abroun, S. miR-4284 and miR-4484 as putative biomarkers for diffuse large B-cell lymphoma. Iran. J. Med. Sci. 41, 334\u2013339 (2016).","journal-title":"Iran. J. Med. Sci."},{"key":"50695_CR18","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/odi.12374","volume":"21","author":"J-S Byun","year":"2015","unstructured":"Byun, J.-S., Hong, S.-H., Choi, J.-K., Jung, J.-K. & Lee, H.-J. Diagnostic profiling of salivary exosomal microRNAs in oral lichen planus patients. Oral Dis. 21, 987\u2013993 (2015).","journal-title":"Oral Dis."},{"key":"50695_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13075-016-1054-6","volume":"18","author":"RB Christmann","year":"2016","unstructured":"Christmann, R. B. et al. miR-155 in the progression of lung fibrosis in systemic sclerosis. Arthritis Res. Ther. 18, 155 (2016).","journal-title":"Arthritis Res. Ther."},{"key":"50695_CR20","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1002\/art.34424","volume":"64","author":"J Wei","year":"2012","unstructured":"Wei, J. et al. Wnt\/beta-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells. Arthritis Rheum. 64, 2734\u20132745 (2012).","journal-title":"Arthritis Rheum."},{"key":"50695_CR21","doi-asserted-by":"publisher","first-page":"ra84","DOI":"10.1126\/scisignal.2004592","volume":"7","author":"S Svegliati","year":"2014","unstructured":"Svegliati, S. et al. Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis. Sci. Signal. 7, ra84 (2014).","journal-title":"Sci. Signal."},{"key":"50695_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jaut.2017.05.004","volume":"83","author":"P-S Tsou","year":"2017","unstructured":"Tsou, P.-S. & Sawalha, A. H. Unfolding the pathogenesis of scleroderma through genomics and epigenomics. J. Autoimmun. 83, 73\u201394 (2017).","journal-title":"J. Autoimmun."},{"key":"50695_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/nm.3777","volume":"21","author":"K Palumbo-Zerr","year":"2015","unstructured":"Palumbo-Zerr, K. et al. Orphan nuclear receptor NR4A1 regulates transforming growth factor-beta signaling and fibrosis. Nat. Med. 21, 150\u2013158 (2015).","journal-title":"Nat. Med."},{"key":"50695_CR24","doi-asserted-by":"publisher","first-page":"124624","DOI":"10.1155\/2015\/124624","volume":"2015","author":"AT Dantas","year":"2015","unstructured":"Dantas, A. T. et al. The role of PPAR gamma in systemic sclerosis. PPAR Res. 2015, 124624 (2015).","journal-title":"PPAR Res."},{"key":"50695_CR25","doi-asserted-by":"publisher","first-page":"e13778","DOI":"10.1371\/journal.pone.0013778","volume":"5","author":"J Wei","year":"2010","unstructured":"Wei, J. et al. PPARgamma downregulation by TGFbeta in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis. PLoS One 5, e13778 (2010).","journal-title":"PLoS One"},{"key":"50695_CR26","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1002\/art.11157","volume":"48","author":"Y Mori","year":"2003","unstructured":"Mori, Y., Chen, S.-J. & Varga, J. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts. Arthritis Rheum. 48, 1964\u20131978 (2003).","journal-title":"Arthritis Rheum."},{"key":"50695_CR27","doi-asserted-by":"publisher","first-page":"e0139179","DOI":"10.1371\/journal.pone.0139179","volume":"10","author":"M Ruff","year":"2015","unstructured":"Ruff, M. et al. The disintegrin and metalloprotease ADAM12 is associated with TGF-beta-induced epithelial to mesenchymal transition. PLoS One 10, e0139179 (2015).","journal-title":"PLoS One"},{"key":"50695_CR28","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1046\/j.1523-1755.2003.00009.x","volume":"63","author":"K-I Tsuchida","year":"2003","unstructured":"Tsuchida, K.-I., Zhu, Y., Siva, S., Dunn, S. R. & Sharma, K. Role of Smad4 on TGF-beta;induced extracellular matrix stimulation in mesangial cells. Kidney Int. 63, 2000\u20132009 (2003).","journal-title":"Kidney Int."},{"key":"50695_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/srep07596","volume":"4","author":"S Tsukamoto","year":"2014","unstructured":"Tsukamoto, S. et al. Smad9 is a new type of transcriptional regulator in bone morphogenetic protein signaling. Sci. Rep. 4, 7596 (2014).","journal-title":"Sci. Rep."},{"key":"50695_CR30","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1093\/rheumatology\/keu155","volume":"54","author":"N Altorok","year":"2015","unstructured":"Altorok, N., Almeshal, N., Wang, Y. & Kahaleh, B. Epigenetics, the holy grail in the pathogenesis of systemic sclerosis. Rheumatology (Oxford). 54, 1759\u20131770 (2015).","journal-title":"Rheumatology (Oxford)."},{"key":"50695_CR31","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3899\/jrheum.150996","volume":"43","author":"P Cipriani","year":"2016","unstructured":"Cipriani, P. et al. Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis. J. Rheumatol. 43, 1340\u20131349 (2016).","journal-title":"J. Rheumatol."},{"key":"50695_CR32","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1468-3083.2012.04558.x","volume":"27","author":"T Taniguchi","year":"2013","unstructured":"Taniguchi, T. et al. Serum levels of ADAM12-S: possible association with the initiation and progression of dermal fibrosis and interstitial lung disease in patients with systemic sclerosis. J. Eur. Acad. Dermatol. Venereol. 27, 747\u2013753 (2013).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"50695_CR33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.matbio.2015.03.005","volume":"44\u201346","author":"V Arpino","year":"2015","unstructured":"Arpino, V., Brock, M. & Gill, S. E. The role of TIMPs in regulation of extracellular matrix proteolysis. Matrix Biol. 44\u201346, 247\u2013254 (2015).","journal-title":"Matrix Biol."},{"key":"50695_CR34","doi-asserted-by":"publisher","first-page":"14046","DOI":"10.1074\/jbc.275.19.14046","volume":"275","author":"WR English","year":"2000","unstructured":"English, W. R. et al. Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2. J. Biol. Chem. 275, 14046\u201314055 (2000).","journal-title":"J. Biol. Chem."},{"key":"50695_CR35","doi-asserted-by":"crossref","unstructured":"Fonseca, C. et al. A polymorphism in the CTGF promoter region associated with systemic sclerosis. N Engl J Med 357 (2007).","DOI":"10.1056\/NEJMoa067655"},{"key":"50695_CR36","doi-asserted-by":"publisher","first-page":"18812","DOI":"10.1074\/jbc.M801384200","volume":"283","author":"Y Yang","year":"2008","unstructured":"Yang, Y., Tetreault, M.-P., Yermolina, Y. A., Goldstein, B. G. & Katz, J. P. Kr\u00fcppel-like factor 5 controls keratinocyte migration via the integrin-linked kinase. J. Biol. Chem. 283, 18812\u201318820 (2008).","journal-title":"J. Biol. Chem."},{"key":"50695_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6797","volume":"5","author":"S Noda","year":"2014","unstructured":"Noda, S. et al. Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis. Nat. Commun. 5, 5797 (2014).","journal-title":"Nat. Commun."},{"key":"50695_CR38","doi-asserted-by":"crossref","first-page":"43791","DOI":"10.18632\/oncotarget.6101","volume":"6","author":"Y Gao","year":"2015","unstructured":"Gao, Y. et al. Beyond proliferation: KLF5 promotes angiogenesis of bladder cancer through directly regulating VEGFA transcription. Oncotarget 6, 43791\u201343805 (2015).","journal-title":"Oncotarget"},{"key":"50695_CR39","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1042\/bj20030174","volume":"372","author":"GN Marchenko","year":"2003","unstructured":"Marchenko, G. N., Marchenko, N. D. & Strongin, A. Y. The structure and regulation of the human and mouse matrix metalloproteinase-21 gene and protein. Biochem. J. 372, 503\u2013515 (2003).","journal-title":"Biochem. J."},{"key":"50695_CR40","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1600-0625.2006.00460.x","volume":"15","author":"T Skoog","year":"2006","unstructured":"Skoog, T. et al. MMP-21 is expressed by macrophages and fibroblasts in vivo and in culture. Exp. Dermatol. 15, 775\u2013783 (2006).","journal-title":"Exp. Dermatol."},{"key":"50695_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0378-1119(02)01088-0","volume":"301","author":"K Ahokas","year":"2002","unstructured":"Ahokas, K. et al. Matrix metalloproteinase-21, the human orthologue for XMMP, is expressed during fetal development and in cancer. Gene 301, 31\u201341 (2002).","journal-title":"Gene"},{"key":"50695_CR42","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1097\/01.LAB.0000106721.86126.39","volume":"83","author":"K Ahokas","year":"2003","unstructured":"Ahokas, K. et al. Matrix metalloproteinase-21 is expressed epithelially during development and in cancer and is up-regulated by transforming growth factor-\u03b21 in keratinocytes. Lab. Investig. 83, 1887 (2003).","journal-title":"Lab. Investig."},{"key":"50695_CR43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1046\/j.1523-1747.2002.01790.x","volume":"119","author":"U Saarialho-Kere","year":"2002","unstructured":"Saarialho-Kere, U. et al. Epilysin (MMP-28) expression is associated with cell proliferation during epithelial repair. J. Invest. Dermatol. 119, 14\u201321 (2002).","journal-title":"J. Invest. Dermatol."},{"key":"50695_CR44","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S1359-6101(03)00005-4","volume":"14","author":"AG Li","year":"2003","unstructured":"Li, A. G., Koster, M. I. & Wang, X. J. Roles of TGFbeta signaling in epidermal\/appendage development. Cytokine Growth Factor Rev. 14, 99\u2013111 (2003).","journal-title":"Cytokine Growth Factor Rev."},{"key":"50695_CR45","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/ng.3376","volume":"47","author":"A Guimier","year":"2015","unstructured":"Guimier, A. et al. MMP21 is mutated in human heterotaxy and is required for normal left-right asymmetry in vertebrates. Nat. Genet. 47, 1260\u20131263 (2015).","journal-title":"Nat. Genet."},{"key":"50695_CR46","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1590\/S0100-879X2005001000009","volume":"38","author":"V Lagente","year":"2005","unstructured":"Lagente, V. et al. Role of matrix metalloproteinases in the development of airway inflammation and remodeling. Brazilian J. Med. Biol. Res. = Rev. Bras. Pesqui. medicas e Biol. 38, 1521\u20131530 (2005).","journal-title":"Brazilian J. Med. Biol. Res. = Rev. Bras. Pesqui. medicas e Biol."},{"key":"50695_CR47","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen, F. et al. Classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann. Rheum. Dis. 72, 1747\u20131755 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"50695_CR48","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy, E. C. et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J. Rheumatol. 15, 202\u2013205 (1988).","journal-title":"J. Rheumatol."},{"key":"50695_CR49","doi-asserted-by":"publisher","first-page":"D239","DOI":"10.1093\/nar\/gkv1258","volume":"44","author":"C-H Chou","year":"2016","unstructured":"Chou, C.-H. et al. miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database. Nucleic Acids Res. 44, D239\u201347 (2016).","journal-title":"Nucleic Acids Res."},{"key":"50695_CR50","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.mvr.2016.11.006","volume":"110","author":"M Michalska-Jakubus","year":"2017","unstructured":"Michalska-Jakubus, M., Kowal-Bielecka, O., Smith, V., Cutolo, M. & Krasowska, D. Plasma endothelial microparticles reflect the extent of capillaroscopic alterations and correlate with the severity of skin involvement in systemic sclerosis. Microvasc. Res. 110, 24\u201331 (2017).","journal-title":"Microvasc. Res."},{"key":"50695_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0024145","volume":"6","author":"MB Kirschner","year":"2011","unstructured":"Kirschner, M. B. et al. Haemolysis during sample preparation alters microRNA content of plasma. PLoS One 6, 1\u20139 (2011).","journal-title":"PLoS One"},{"key":"50695_CR52","doi-asserted-by":"crossref","unstructured":"Kirschner, M. B., van Zandwijk, N. & Reid, G. Cell-free microRNAs: potential biomarkers in need of standardized reporting. Frontiers in Genetics 4 (2013).","DOI":"10.3389\/fgene.2013.00056"},{"key":"50695_CR53","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ymeth.2010.01.032","volume":"50","author":"EM Kroh","year":"2010","unstructured":"Kroh, E. M., Parkin, R. K., Mitchell, P. S. & Tewari, M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50, 298\u2013301 (2010).","journal-title":"Methods"},{"key":"50695_CR54","doi-asserted-by":"crossref","unstructured":"Agarwal, V., Bell, G. W., Nam, J.-W. & Bartel, D. P. Predicting effective microRNA target sites in mammalian mRNAs. Elife 4 (2015).","DOI":"10.7554\/eLife.05005"},{"key":"50695_CR55","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15\u201320 (2005).","journal-title":"Cell"},{"key":"50695_CR56","doi-asserted-by":"publisher","first-page":"D146","DOI":"10.1093\/nar\/gku1104","volume":"43","author":"N Wong","year":"2015","unstructured":"Wong, N. & Wang, X. miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res. 43, D146\u2013D152 (2015).","journal-title":"Nucleic Acids Res."},{"key":"50695_CR57","doi-asserted-by":"publisher","first-page":"D153","DOI":"10.1093\/nar\/gku1215","volume":"43","author":"IS Vlachos","year":"2015","unstructured":"Vlachos, I. S. et al. DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions. Nucleic Acids Res. 43, D153\u20139 (2015).","journal-title":"Nucleic Acids Res."},{"key":"50695_CR58","first-page":"D530","volume":"41","author":"JA Blake","year":"2013","unstructured":"Blake, J. A. et al. Gene Ontology annotations and resources. Nucleic Acids Res. 41, D530\u20135 (2013).","journal-title":"Nucleic Acids Res."},{"key":"50695_CR59","doi-asserted-by":"publisher","first-page":"D109","DOI":"10.1093\/nar\/gkr988","volume":"40","author":"M Kanehisa","year":"2012","unstructured":"Kanehisa, M., Goto, S., Sato, Y., Furumichi, M. & Tanabe, M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 40, D109\u201314 (2012).","journal-title":"Nucleic Acids Res."},{"key":"50695_CR60","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00246-016-1487-3","volume":"38","author":"W Chen","year":"2017","unstructured":"Chen, W. & Li, S. Circulating microRNA as a Novel Biomarker for Pulmonary Arterial Hypertension Due to Congenital Heart Disease. Pediatr. Cardiol. 38, 86\u201394 (2017).","journal-title":"Pediatr. Cardiol."},{"key":"50695_CR61","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nrrheum.2014.53","volume":"10","author":"YY Ho","year":"2014","unstructured":"Ho, Y. Y., Lagares, D., Tager, A. M. & Kapoor, M. Fibrosis\u2014a lethal component of systemic sclerosis. Nat. Rev. Rheumatol. 10, 390 (2014).","journal-title":"Nat. Rev. Rheumatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50695-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50695-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50695-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T14:14:52Z","timestamp":1671286492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50695-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,3]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["50695"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-50695-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,3]]},"assertion":[{"value":"10 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14264"}}